Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.


Cancer cured by measles vaccine

19 May 2014, 19:01

Abuja - The trial, which took place in the US, involved injecting two sufferers with a dose of the measles vaccine 10 000 times stronger than that used for normal vaccination. One of the sufferers experienced a total remission with all of her tumours vanishing. The other experienced a remission but her cancer soon returned, indicating the treatment might not work for all sufferers.

The mechanism underlying the cure involves the injected virus latching on to the cancerous cells, particularly those found in tumours. The virus then destroys these cells, causing the tumours to disappear. Myeloma, however, is not restricted to tumours as it infects the bone marrow as well. The measles treatment completely cleared the bone marrow of any cancerous cells, meaning the patient was essentially cancer-free.

This came after the patient had exhausted every other treatment option available, including radiation and chemotherapy. Adding another kind of treatment to those currently available should increase the number of cases that can be successfully treated, boosting survival rates.

Multiple Myeloma kills over 70 000 people a year worldwide with a 5-year survival rate of only around 45%, making it one of the deadlier forms of cancer in the world today.

Treating cancer with other diseases has been trialled several times before, with mixed success. The problem lies in the fact that cancer is such a diverse illness. No single disease can be used to treat every cancer, meaning scientists have to spend time determining which disease is best suited to the targeted cancer. Because it led to complete remission, this is the most successful trial to date.

Obviously, results from two patients do not constitute significant evidence, but it is a cause for optimism. The Mayo Clinic plans to build on this discovery with a large-scale trial that will be launched by the end of the year.

- Health24

For the latest on national news, politics, sport, entertainment and more follow us on Twitter and like our Facebook page!


Read News24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Read more from our Users

Nigeria @ 56: Words to my green f...

A leader’s job is not to dictate, but rather to be respected, admired and be a trustee, of the land we love, with so much potential, a land which should be freer than free. Its still a long way to fufilling our destiny! Read more...

Submitted by
Isaac Asabor263
Recession: An opportunity for Nig...

The recession should be seen as an opportunity for the country’s promotion as long as we all collectively conduct ourselves in a patriotic manner, writes Isaac Asabor.  Read more...

Submitted by
Black and White

We want to imitate the whites in everything because we are ignorant of our inherent originality and content. We spend all our Naira to acquire his inventions because we so oblivious of our natural endowments that we allow him have it for free. Read more...

Submitted by
Nate Nat
Adamawa State University Mubi: A ...

ADSU integrity forum has accused the Sunday Joshua Wugira, a lawyer, of adopting unorthodox tactics by abusing his privilege by attacking the integrity of ADSU Vice Chancellor Dr. Moses Zira Zaruwa, writes a News24 reader. Read more...

Submitted by
Abdulsalam Jubril
My Country Nigeria (Part One)

Poetry by Abdulsalam Jubril.

Submitted by
Abdulsalam Jubril
Recession, dearth in leadership a...

Every leader has the opportunity to become great and making himself immortal in the lives and hearts of people for generations to come. Will Mr. President seize this opportunity?, questions Abdulsalam Jubril. Read more...